活動詳情

APACMed China Digital Health Regulatory Webinar

(The webinar will be conducted in Chinese Mandarin)


To ensure science-based regulation of medical products, regulators around the world have been constantly adapting to the fast-changing regulatory environment due to rapid development of technological innovations. In 2021, APACMed released a paper- Digital Health Regulation in Asia-Pacific: China And Korea which compared the Digital Health regulatory framework and best practices of Korea and China. To better understand the regulatory landscape of China and how industry might work together to support digital health transformation in China, APACMed China is hosting this webinar to discuss the latest policy evolvement in China, thus building consensus from the industry to explore new opportunities in China's digital health landscape.



亚太医疗技术协会数字医疗系列研讨会

-中国数字健康法规专题

时间:2022年2月25日(周五)上午10点 - 11点


当前,世界各国监管机构均在不断适应快速变化的法规环境,技术的迭代更新,以实现更加科学的监管,数字医疗领域也不例外。 亚太医疗技术协会作为亚太地区唯一的医疗技术行业协会,相继于2020年和2021年发布了《亚太地区数字健康概况及最佳实践》报告及《中韩数字健康法规对比报告》,对比了亚太地区主流国家在数字健康方面的监管框架和实践,涉及澳大利亚、日本、 新加坡、韩国及中国等。本次专题研讨会将聚焦中国在医疗器械软件监管方面的最新做法,汇聚产业界共识,为下一步配合科学监管奠定基础。

2022年02月25日

10:00 - 11:00 GMT+8

活動日程

  • 10:00 - 10:05Opening 开场白

    Alicia Chang (APACMed)

    Country Lead, APACMed China

    10:05 - 10:10Keynote 主旨发言
    Digital Health Policies and Prospect of Pilot Zones of China- A Hainan Perspective

    海南数字医疗发展最新政策解读

    Dr. Zhang Yuhui

    DDG, Hainan Health Commission

    10:10 - 10:20Keynote 主旨发言
    Key Technical Points of Digital Health Regulation in China

    中国数字疗法产品最新法规要点

    Liu Zhongsheng

    Director of Software and Cybersecurity Office, CMTC

    10:20 - 10:30Keynote 主题分享
    Digital Health Regulation in Asia-Pacific: China & Korea

    《中韩数字健康法规对比研究报告》分享

    Wang Ping

    Senior RA Manager, ResMed China

    10:30 - 10:55Panel Discussion 小组讨论
    Looking into the future of digital health in China

    中国数字健康的未来

    Liu Zhongsheng

    Director of Software and Cybersecurity Office, CMTC

    Tony Liu

    General Manager, ResMed China

    Qiman (Annie) Yin

    Vice President, Medical Regulatory Affairs, Roche Diagnostic (China)

    Chen Bingshu

    Vice President, Infervision

    Sherry Li

    Commercial Director, Mainland China & Hong Kong, Abbott Diabetes Care

    Song Yiran (Moderator)

    Managing Director, Marathon Venture Partner

    10:55 - 11:00Closing 总结

    Alicia Chang (APACMed)

    Country Lead, APACMed China

演講嘉賓

  • Dr. Zhang Yuhui (DDG, Hainan Health Commission)

    Dr. Zhang Yuhui

    DDG, Hainan Health Commission

    簡介
  • Liu Zhongsheng (Director of Software and Cybersecurity Office, CMTC)

    Liu Zhongsheng

    Director of Software and Cybersecurity Office, CMTC

    簡介
  • Tony Liu (General Manager, ResMed China)

    Tony Liu

    General Manager, ResMed China

    簡介
  • Wang Ping (Senior RA Manager, ResMed China)

    Wang Ping

    Senior RA Manager, ResMed China

    簡介
  • Qiman (Annie) Yin (Vice President, Medical Regulatory Affairs, Roche Diagnostic (China))

    Qiman (Annie) Yin

    Vice President, Medical Regulatory Affairs, Roche Diagnostic (China)

    簡介
  • Chen Bingshu (Vice President, Infervision)

    Chen Bingshu

    Vice President, Infervision

    簡介
  • Sherry Li (Commercial Director, Mainland China & Hong Kong, Abbott Diabetes Care)

    Sherry Li

    Commercial Director, Mainland China & Hong Kong, Abbott Diabetes Care

    簡介
  • Song Yiran (Moderator) (Managing Director, Marathon Venture Partner)

    Song Yiran (Moderator)

    Managing Director, Marathon Venture Partner

    簡介
  • Alicia Chang (APACMed) (Country Lead, APACMed China)

    Alicia Chang (APACMed)

    Country Lead, APACMed China

    簡介

社區

聯系該活動與會者中的167個人

菜單